药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Ethylmorphine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethylmorphine.
Potassium cation
Fencamfamin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fencamfamin.
Potassium cation
Diamorphine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diamorphine.
Potassium cation
Dihydroetorphine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydroetorphine.
Potassium cation
Bufotenine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bufotenine.
Potassium cation
MMDA
The risk or severity of adverse effects can be increased when Cannabidiol is combined with MMDA.
Potassium cation
Glutethimide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Glutethimide.
Potassium cation
Methadyl acetate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methadyl acetate.
Potassium cation
Yohimbine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Yohimbine.
Potassium cation
Rasagiline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rasagiline.
Potassium cation
Penbutolol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Penbutolol.
Potassium cation
Lithium cation
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lithium cation.
Potassium cation
Hexobarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexobarbital.
Potassium cation
Heptabarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Heptabarbital.
Potassium cation
Butobarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butobarbital.
Potassium cation
Aprobarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aprobarbital.
Potassium cation
Amobarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amobarbital.
Potassium cation
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Cannabidiol.
Potassium cation
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Cannabidiol.
Potassium cation
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Cannabidiol.